Insider · CIK 0002063899
Dean Anthony Caruvana
Files at XSPIX (StepStone Private Venture & Growth Fund), StepStone Private Equity Strategies Fund. First filing Apr 28, 2025, latest Dec 17, 2025.
Dean Anthony Caruvana files SEC Form 4 as officer at StepStone Private Equity Strategies Fund, and also at XSPIX (StepStone Private Venture & Growth Fund). Since Apr 28, 2025, Dean Anthony Caruvana has reported 5 open-market buys worth $450k and 0 open-market sells worth $0, the latest filed on Dec 17, 2025.
A track record needs three past buys with six months of prices behind them; Dean Anthony Caruvana has 0, so none is measured yet.
The newest scored trade: bought $50k of XSPIX on Dec 15, 2025, filed Dec 17, 2025, scored 36 (weak). In the last 12 months: 1 buy worth $50k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XSPIX: StepStone Private Venture & Growth Fund
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | StepStone Private Venture & Growth Fund | $50k 957 shares | +41% | - | |
| 55Moderate | -buy 5 StepStone Private Equity Strategies Fund | $100k 10,000 shares | +100% | - | |
| 48Moderate | -buy 5 StepStone Private Equity Strategies Fund | $100k 10,000 shares | - | - | |
| 48Moderate | -buy 5 StepStone Private Equity Strategies Fund | $100k 10,000 shares | - | - | |
| 33Weak | XSPIXbuy StepStone Private Venture & Growth Fund | $100k 2,314 shares | - | - |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | XSPIX StepStone Private Venture & Growth Fund | POpen-market purchase Class I Common Shares of Beneficial Interest | +957 | $52.27 | $50k | 3,270 | Dec 17, 2025 |
| Sep 10, 2025 | - StepStone Private Equity Strategies Fund | POpen-market purchase Class I Shares | +5,000 | $10.00 | $50k | 15,000 | Sep 15, 2025 |
| Sep 8, 2025 | - StepStone Private Equity Strategies Fund | POpen-market purchase Class I Shares | +5,000 | $10.00 | $50k | 5,000 | Sep 15, 2025 |
| Sep 11, 2025 | - StepStone Private Equity Strategies Fund | POpen-market purchase Class I Shares | +5,000 | $10.00 | $50k | 20,000 | Sep 15, 2025 |
| Sep 9, 2025 | - StepStone Private Equity Strategies Fund | POpen-market purchase Class I Shares | +5,000 | $10.00 | $50k | 10,000 | Sep 15, 2025 |
| Sep 8, 2025 | - StepStone Private Equity Strategies Fund | POpen-market purchase Class I Shares | +10,000 | $10.00 | $100k | 10,000 | Sep 10, 2025 |
| Apr 24, 2025 | XSPIX StepStone Private Venture & Growth Fund | POpen-market purchase Class I Common Shares of Beneficial Interest | +2,314 | $43.22 | $100k | 2,314 | Apr 28, 2025 |
Questions about Dean Anthony Caruvana
Answered from the filings on this page, as of the latest one.
Is Dean Anthony Caruvana buying or selling?
In the last 12 months Dean Anthony Caruvana reported 1 open-market buy worth $50k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $50k of XSPIX on Dec 15, 2025. Grants, option exercises and tax withholding are not counted.
How did Dean Anthony Caruvana's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dean Anthony Caruvana has 0.
Where does Dean Anthony Caruvana file Form 4?
Dean Anthony Caruvana has filed Form 4 at StepStone Private Equity Strategies Fund as CCO and Corporate Secretary; XSPIX (StepStone Private Venture & Growth Fund) as Secretary & Chief Compli. Off.. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.